State Street Corp Ocugen, Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Ocugen, Inc. stock. As of the latest transaction made, State Street Corp holds 1,338,919 shares of OCGN stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,338,919

Previous 5,932,041 77.43%

Holding current value

$1.61 Million

Previous $4.21 Million 69.18%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.58 - $1.2 $2.66 Million - $5.51 Million	-4,593,122 Reduced 77.43%	1,338,919 $1.3 Million
Q1 2025 May 15, 2025	BUY	$0.52 - $0.9 $34,285 - $59,339	65,933 Added 1.12%	5,932,041 $4.21 Million
Q4 2024 Feb 14, 2025	SELL	$0.72 - $1.08 $7.17 Million - $10.8 Million	-9,958,409 Reduced 62.93%	5,866,108 $4.69 Million
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $1.03 Million - $2.04 Million	1,047,896 Added 7.09%	15,824,517 $15.7 Million
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.98 $16.3 Million - $27.4 Million	13,819,895 Added 1444.5%	14,776,621 $22.9 Million
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $60,450 - $221,247	120,900 Added 14.46%	956,726 $1.57 Million
Q4 2023 Feb 14, 2024	SELL	$0.36 - $0.57 $16,488 - $26,105	-45,800 Reduced 5.19%	835,826 $476,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $2.35 Million - $4.6 Million	-5,232,485 Reduced 85.58%	881,626 $476,000
Q1 2023 May 15, 2023	SELL	$0.82 - $1.33 $19.7 Million - $31.9 Million	-24,006,913 Reduced 79.7%	6,114,111 $5.2 Million
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.87 $4.57 Million - $7.69 Million	4,113,822 Added 15.82%	30,121,024 $39.2 Million
Q3 2022 Nov 15, 2022	SELL	$1.75 - $3.1 $8.07 Million - $14.3 Million	-4,610,744 Reduced 15.06%	26,007,202 $46.3 Million
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $2.68 Million - $5.05 Million	1,464,242 Added 5.02%	30,617,946 $69.5 Million
Q1 2022 May 16, 2022	BUY	$2.34 - $4.72 $35.4 Million - $71.4 Million	15,136,085 Added 107.98%	29,153,704 $96.2 Million
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $11.8 Million - $42.3 Million	2,700,103 Added 23.86%	14,017,619 $63.8 Million
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $2.94 Million - $3.93 Million	461,546 Added 4.25%	11,317,516 $81.3 Million
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $32.1 Million - $91.3 Million	5,822,035 Added 115.66%	10,855,970 $87.2 Million
Q1 2021 May 17, 2021	BUY	$1.66 - $15.81 $8.34 Million - $79.4 Million	5,023,635 Added 48773.16%	5,033,935 $34.2 Million
Q4 2020 Feb 16, 2021	BUY	$0.28 - $2.6 $2,884 - $26,780	10,300 New	10,300 $19,000

Others Institutions Holding OCGN

# of Institutions

112

Shares Held

64.6M

Call Options Held

604K

Put Options Held

253K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $260M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ocugen, Inc. Transaction History